Chemotherapeutic activity of benzoxazinorifamycin, KRM-1648, against Mycobacterium tuberculosis in C57BL/6 mice
- 30 April 1996
- journal article
- Published by Elsevier BV in Tubercle and Lung Disease
- Vol. 77 (2), 154-159
- https://doi.org/10.1016/s0962-8479(96)90030-1
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Therapeutic effect of KRM-1648 with various antimicrobials against Mycobacterium avium complex infection in miceTubercle and Lung Disease, 1995
- In vitro activity of the benzoxazinorifamycin KRM-1648 against drug-susceptible and multidrug-resistant tubercle bacilliAntimicrobial Agents and Chemotherapy, 1995
- Activity of KRM-1648, a new benzoxazinorifamycin, against Mycobacterium tuberculosis in a murine modelAntimicrobial Agents and Chemotherapy, 1994
- In vivo activity of paromomycin against susceptible and multidrug-resistant Mycobacterium tuberculosis and M. avium complex strainsAntimicrobial Agents and Chemotherapy, 1994
- The early bactericidal activity of rifabutin in patients with pulmonary tuberculosis measured by sputum viable counts: a new method of drug assessmentJournal of Antimicrobial Chemotherapy, 1993
- Chemotherapeutic efficacy of a newly synthesized benzoxazinorifamycin, KRM-1648, against Mycobacterium avium complex infection induced in miceAntimicrobial Agents and Chemotherapy, 1992
- In vitro antimycobacterial activities of newly synthesized benzoxazinorifamycinsAntimicrobial Agents and Chemotherapy, 1991
- Some Observations on the Pathogenicity of Isoniazid-Resistant Variants of Tubercle BacilliScience, 1953